Correction: Gene expression profiling identifies FYN as an important molecule in tamoxifen resistance and a predictor of early recurrence in patients treated with endocrine therapy.

Autor: Elias D; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark. delias@health.sdu.dk., Vever H; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark., Lænkholm AV; Department of Pathology, Slagelse Hospital, Slagelse, Denmark., Gjerstorff MF; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark., Yde CW; Breast Cancer Group, Cell Death and Metabolism, Danish Cancer Society Research Center, Copenhagen, Denmark., Lykkesfeldt AE; Breast Cancer Group, Cell Death and Metabolism, Danish Cancer Society Research Center, Copenhagen, Denmark., Ditzel HJ; Department of Cancer and Inflammation Research, Institute of Molecular Medicine, University of Southern Denmark, Odense, Denmark. hditzel@health.sdu.dk.; Department of Oncology, Odense University Hospital, Odense, Denmark. hditzel@health.sdu.dk.
Jazyk: angličtina
Zdroj: Oncogene [Oncogene] 2020 Mar; Vol. 39 (10), pp. 2229-2230.
DOI: 10.1038/s41388-019-1096-8
Abstrakt: An amendment to this paper has been published and can be accessed via a link at the top of the paper.
Databáze: MEDLINE
Externí odkaz: